Left Ventricular Ejection Fraction Reductions During Long-Term Aficamten Treatment in Obstructive Hypertrophic Cardiomyopathy: Findings From FOREST-HCM
Journal of Cardiac Failure · 2026-11
DOI: 10.1016/j.cardfail.2026.09.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiac Failure, 2026-11. Verfasst von Daniele Massera und 20 weiteren Autor:innen. Beteiligte Einrichtung: Leon H. Charney Division of Cardiology, NYU Langone Health, New York, NY, USA. Electronic address: daniele.massera@nyulangone.org. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cytokinetics Inc.
Abstract (Originalsprache)
Obstructive hypertrophic cardiomyopathy (oHCM) is characterized by left ventricular (LV) hypercontractility and dynamic LV outflow tract obstruction, which independently predict heart failure progression and mortality.1 Cardiac myosin inhibitors alleviate LV outflow tract obstruction by reducing excessive actin-myosin cross-bridge formation, thereby lowering contractile force, relieving dynamic obstruction, and improving symptoms and exercise capacity.2 An expected pharmacodynamic consequence of this mechanism is a reduction in LV ejection fraction (LVEF); in some patients, this reduction may be excessive, resulting in LV systolic dysfunction (LVSD, defined as site-read LVEF
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Leon H. Charney Division of Cardiology, NYU Langone Health, New York, NY, USA. Electronic address: daniele.massera@nyulangone.org.
- University of Pennsylvania, Philadelphia, PA, USA.
- University of California San Francisco, San Francisco, CA, USA.
- Complejo Hospitalario Universitario de A Coruña, INIBIC, CIBERCV-ISCIII, A Coruña, Spain.
- Liverpool John Moores University, Liverpool, UK.
- Barts Heart Centre and University College London, London, UK.
Förderung
- Cytokinetics Inc
Zitieren
APA
Massera, D., Owens, A., Abraham, T. P., Barriales-Villa, R., Cooper, R. M., Elliott, P. M., Maron, M. S., Nassif, M. E., Oreziak, A., Saberi, S., Solomon, S. D., Tower-Rader, A., Godown, J., Heitner, S. B., Jacoby, D. L., Kupfer, S., Liu, X., Malik, F. I., Sohn, R., …, & Masri, A. (2026). Left Ventricular Ejection Fraction Reductions During Long-Term Aficamten Treatment in Obstructive Hypertrophic Cardiomyopathy: Findings From FOREST-HCM. Journal of Cardiac Failure. https://doi.org/10.1016/j.cardfail.2026.09.013
Vancouver
Massera D, Owens A, Abraham TP, Barriales-Villa R, Cooper RM, Elliott PM, et al. Left Ventricular Ejection Fraction Reductions During Long-Term Aficamten Treatment in Obstructive Hypertrophic Cardiomyopathy: Findings From FOREST-HCM. Journal of Cardiac Failure. 2026. doi:10.1016/j.cardfail.2026.09.013
BibTeX
@article{Massera2026,
author = {Massera, Daniele and Owens, Anjali and Abraham, Theodore P and Barriales-Villa, Roberto and Cooper, Robert M and Elliott, Perry M and Maron, Martin S and Nassif, Michael E and Oreziak, Artur and Saberi, Sara and Solomon, Scott D and Tower-Rader, Albree and Godown, Justin and Heitner, Stephen B and Jacoby, Daniel L and Kupfer, Stuart and Liu, Xueli and Malik, Fady I and Sohn, Regina and Wei, Jenny and Masri, Ahmad},
title = {Left Ventricular Ejection Fraction Reductions During Long-Term Aficamten Treatment in Obstructive Hypertrophic Cardiomyopathy: Findings From FOREST-HCM},
journal = {Journal of Cardiac Failure},
year = {2026},
doi = {10.1016/j.cardfail.2026.09.013}
}
EUVIMED